| CXHB2000027 | 丁二酸复瑞替尼胶囊 | SAF-189s | Capsule | Chemical Drugs | Supplementary Application | 2020-04-15 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | In Review | 2020-04-14 | view |
| CXHB2000028 | 丁二酸复瑞替尼胶囊 | SAF-189s | Capsule | Chemical Drugs | Supplementary Application | 2020-04-15 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | In Review | 2020-04-14 | view |
| CXHL1700350 | 万格列净 | | Active ingredient | Chemical Drugs(1) | New Drug Application | 2018-01-31 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | In Review | 2018-01-29 | view |
| CXHL1700351 | 万格列净片 | | Tablet | Chemical Drugs(1) | New Drug Application | 2018-02-07 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2018-07-06 | view |
| CXHL1700352 | 万格列净片 | | Tablet | Chemical Drugs(1) | New Drug Application | 2018-02-07 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2018-07-06 | view |
| CXHL1700353 | 万格列净片 | | Tablet | Chemical Drugs(1) | New Drug Application | 2018-02-07 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2018-07-06 | view |
| CXSL1700209 | 利拉鲁肽 | liraglutide | Active ingredient | Biological Products(10) | New Drug Application | 2018-02-14 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | In Review | 2018-02-12 | view |
| CXSL1700210 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products(10) | New Drug Application | 2018-02-14 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | In Review | 2018-02-12 | view |
| CXSL1900149 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products(7) | New Drug Application | 2019-12-26 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | In Review | 2019-12-25 | view |
| CXSL2000109 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(15) | New Drug Application | 2020-05-30 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | In Review | 2020-05-29 | view |
| CXSL2000110 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(15) | New Drug Application | 2020-05-30 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | In Review | 2020-05-29 | view |
| CXSS2000009 | 重组甘精胰岛素注射液 | insulin glargine | Injection | Biological Products(15) | New Drug Application | 2020-03-19 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | In Review | 2020-03-17 | view |
| CXSS2000034 | 重组赖脯胰岛素注射液 | insulin lispro | Injection | Biological Products(15) | New Drug Application | 2020-06-28 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | In Review | 2020-06-24 | view |
| CYHB1850042 | 格列美脲片 | glimepiride | Tablet | Chemical Drugs | Supplementary Application | 2018-05-10 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2019-01-25 | view |
| CYHB1850043 | 格列美脲片 | glimepiride | Tablet | Chemical Drugs | Supplementary Application | 2018-05-10 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2019-01-25 | view |
| CYHB1950415 | 匹伐他汀钙片 | pitavastatin calcium | Tablet | Chemical Drugs | Supplementary Application | 2019-06-12 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2020-04-22 | view |
| CYHB1950416 | 匹伐他汀钙片 | pitavastatin calcium | Tablet | Chemical Drugs | Supplementary Application | 2019-06-12 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2020-04-22 | view |
| CYHB1950424 | 非布司他片 | febuxostat | Tablet | Chemical Drugs | Supplementary Application | 2019-06-14 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2020-04-16 | view |
| CYHB1950425 | 非布司他片 | febuxostat | Tablet | Chemical Drugs | Supplementary Application | 2019-06-14 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2020-04-16 | view |
| CYHB2002803 | 非布司他片 | febuxostat | Tablet | Chemical Drugs | Supplementary Application | 2020-04-27 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2020-09-10 | view |
